http://www.cardiffoncology.com
Cardiff Oncology, Inc. Company Intro
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Industry
Healthcare
Cardiff Oncology, Inc. Headquaters
11055 Flintkote Avenue
San Diego,92121
United States
Cardiff Oncology, Inc. Share price
14 Sep 2022 08:59 GMT
$2.5000
-0.71 (-22.12 %)
Cardiff Oncology, Inc. Market cap
$79.311 M
WMC RANKING
2022
Cardiff Oncology, Inc. # 301
BiotechnologyLatest Cardiff Oncology, Inc. News
01 Dec 2022
Pancreatic Ductal Adenocarcinoma Pipeline Drugs and ...
CEND-1: Cend Therapeutics Inc. Onvansertib: Cardiff Oncology; YH003: Eucure Biopharma; KN046: Jiangsu Alphamab Biopharmaceuticals. Get a Free Sample PDF Report...
01 Dec 2022
Pancreatic Ductal Adenocarcinoma Pipeline Drugs and ...
CEND-1: Cend Therapeutics Inc. Onvansertib: Cardiff Oncology; YH003: Eucure Biopharma; KN046: Jiangsu Alphamab Biopharmaceuticals. Get a Free Sample PDF Report...
WMC Market Score
WMC Market to Revenue Score
Cardiff Oncology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cardiff Oncology, Inc. | USD | $370 | $20,774 | $-23,687 | $793M | 301 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cardiff Oncology, Inc. Social Followers vs Top 4 Industry Competitors
Cardiff Oncology, Inc. Post vs Top 4 Industry Competitors
Cardiff Oncology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Cardiff Oncology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cardiff Oncology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cardiff Oncology, Inc. | 0.00 | 2.33 | 0.01 | 0 | 0 | 0 | 1.09 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
